Literature DB >> 20889191

Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis.

Alper M van Sijl1, Mike J Peters, Dirk K Knol, Henrica C de Vet, Miguel A Gonzalez-Gay, Yvo M Smulders, Ben A Dijkmans, Michael T Nurmohamed.   

Abstract

OBJECTIVES: Rheumatoid arthritis (RA) is associated with increased risk of cardiovascular disease. Carotid intima media thickness (cIMT) is frequently used to identify populations at elevated cardiovascular risk. A systematic literature search and meta-analysis were performed to evaluate cIMT difference between RA and controls.
METHODS: The literature was screened to identify all available studies comparing cIMT in RA patients and controls. Random effects meta-analysis was performed to estimate the overall mean cIMT difference between both groups. Meta-regression was performed to assess the influence of age and the degree of comparability regarding established cardiovascular risk factors on cIMT difference. Potential publication bias was examined by a funnel plot and Egger test.
RESULTS: From 22 studies, cIMT data were available from 1384 RA patients and 1147 controls. In 17 of the studies, RA patients had a statistically significantly greater cIMT. The overall mean cIMT difference was 0.09 mm (95%CI: 0.07-0.11 mm). Heterogeneity was observed (I(2) 72.5%, P < 0.001). A likely source of heterogeneity was the difference in cardiovascular risk factors between RA patients and controls at baseline, but not age. The funnel plot did not show a skewed or asymmetrical shape, which was supported by the Egger's test (P = 0.87).
CONCLUSIONS: Our observations support the current evidence base for an increased cardiovascular burden in RA and support the use of cIMT in observational studies in RA patients. The next step is to determine its utility as a surrogate cardiovascular risk marker in RA in prospective studies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 20889191     DOI: 10.1016/j.semarthrit.2010.06.006

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  49 in total

1.  Preventing Heart Failure in Inflammatory and Immune Disorders.

Authors:  Maya Serhal; Chris T Longenecker
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-06

2.  Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index.

Authors:  Carmen Gómez-Vaquero; Montserrat Robustillo; Javier Narváez; Jesús Rodríguez-Moreno; Carlos González-Juanatey; Javier Llorca; Joan Miquel Nolla; Miguel Angel González-Gay
Journal:  Clin Rheumatol       Date:  2011-05-13       Impact factor: 2.980

3.  Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis.

Authors:  Inmaculada del Rincón; Joseph F Polak; Daniel H O'Leary; Daniel F Battafarano; John M Erikson; Jose F Restrepo; Emily Molina; Agustín Escalante
Journal:  Ann Rheum Dis       Date:  2014-05-20       Impact factor: 19.103

Review 4.  Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.

Authors:  Karen Au; Manjit K Singh; Vijay Bodukam; Sangmee Bae; Paul Maranian; Rikke Ogawa; Brennan Spiegel; Maureen McMahon; Bevra Hahn; Dinesh Khanna
Journal:  Arthritis Rheum       Date:  2011-07

5.  Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors.

Authors:  Aikaterini Arida; Evi Zampeli; George Konstantonis; Kalliope Fragiadaki; George D Kitas; Athanasios D Protogerou; Petros P Sfikakis
Journal:  Clin Rheumatol       Date:  2015-03-11       Impact factor: 2.980

6.  Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment.

Authors:  Cynthia S Crowson; Sherine E Gabriel
Journal:  Ann Rheum Dis       Date:  2011-02-22       Impact factor: 19.103

7.  Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.

Authors:  Edit Végh; György Kerekes; Anita Pusztai; Attila Hamar; Szilvia Szamosi; Andrea Váncsa; Levente Bodoki; Lilla Pogácsás; Fruzsina Balázs; Katalin Hodosi; Andrea Domján; Sándor Szántó; Zoltán Nagy; Zoltán Szekanecz; Gabriella Szűcs
Journal:  Rheumatol Int       Date:  2019-12-17       Impact factor: 2.631

8.  Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis.

Authors:  Peng Wang; Shi-Yang Guan; Shu-Zhen Xu; Hong-Miao Li; Rui-Xue Leng; Xiang-Pei Li; Hai-Feng Pan
Journal:  Clin Rheumatol       Date:  2015-11-27       Impact factor: 2.980

9.  Carotid enlargement and serum levels of von Willebrand factor in rheumatoid arthritis: a follow-up study.

Authors:  Mirjana Veselinovic; Vladimir Jakovljevic; Aleksandra Jurisic-Skevin; Slavco Toncev; Dragan M Djuric
Journal:  Clin Rheumatol       Date:  2012-09-09       Impact factor: 2.980

Review 10.  Novel mechanisms of action of the biologicals in rheumatic diseases.

Authors:  Cecilia Beatrice Chighizola; Ennio Giulio Favalli; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.